Finch announces delisting from nasdaq and sec deregistration

Boston, oct. 21, 2024 (globe newswire) -- finch therapeutics group, inc. (nasdaq: fnch) (“finch” or the “company”), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced that it has provided notification to the nasdaq stock market, llc (“nasdaq”) of its intent to delist the company's common stock, par value $0.001 per share (the “common stock”), from the nasdaq global select market. finch expects to file a form 25 (notification of removal from listing) with the securities and exchange commission (the “sec”) and nasdaq relating to the delisting of its common stock on or about october 31, 2024.
NDAQ Ratings Summary
NDAQ Quant Ranking